Tolerogenic dendritic cells show gene expression profiles that are different from those of immunogenic dendritic cells in DBA/1 mice

References

• Cools, N., P. Ponsaerts, V. F. Van Tendeloo, and Z. N. Berneman. 2007. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 82: 1365–1374
   PubMed Web of Science ®Google Scholar
• Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610–621
   PubMed Web of Science ®Google Scholar
• Kushwah, R., and J. Hu. 2011. Complexity of dendritic cell subsets and their function in the host immune system. Immunology 133: 409–419
   PubMed Web of Science ®Google Scholar
• Kalantari, T., E. Kamali-Sarvestani, B. Ciric, et al. 2011. Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol. Res. 51: 153–160
   PubMed Web of Science ®Google Scholar
• Weng, Y., J. Sun, Q. Wu, and J. Pan. 2007. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells. J. Neuroimmunol. 182: 48–54
   PubMed Web of Science ®Google Scholar
• Chen, Z., J. Lu, N. Srinivasan, et al. 2009. Polysaccharide–protein complex from Lycium barbarum L. is a novel stimulus of dendritic cell immunogenicity. J. Immunol. 182: 3503–3509
   PubMed Web of Science ®Google Scholar
• Greifenberg, V., E. Ribechini, S. Rossner, and M. B. Lutz. 2009. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39: 2865–2876
   PubMed Web of Science ®Google Scholar
• Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70: 345–352
   PubMed Web of Science ®Google Scholar
• Harry, R. A., A. E. Anderson, J. D. Isaacs, and C. M. Hilkens. 2010. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann. Rheum. Dis. 69: 2042–2050
   PubMed Web of Science ®Google Scholar
• Liang, S., V. Ristich, H. Arase, et al. 2008. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6 – STAT3 signaling pathway. Proc. Nat. Acad. Sci. USA. 105: 8357–8362
   PubMed Web of Science ®Google Scholar
• Szeles, L., G. Keresztes, D. Torocsik, et al. 2009. 1,25-Dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 182: 2074–2083
   PubMed Web of Science ®Google Scholar
• Gilboa, E. 2007. DC-based cancer vaccines. J. Clin. Invest. 117: 1195–1203
   PubMed Web of Science ®Google Scholar
• Schadendorf, D., S. Ugurel, B. Schuler-Thurner, et al. 2006. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann. Oncol. 17: 563–570
   PubMed Web of Science ®Google Scholar
• Wilson, N. S., G. M. Behrens, R. J. Lundie, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7: 165–172
   PubMed Web of Science ®Google Scholar
• Chen, W., X. Liang, A. J. Peterson, et al. 2008. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181: 5396–5404
   PubMed Web of Science ®Google Scholar
• Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108: 1435–1440
   PubMed Web of Science ®Google Scholar
• Hadeiba, H., T. Sato, A. Habtezion, et al. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9: 1253–1260
   PubMed Web of Science ®Google Scholar
• Lee, J. H., T. H. Kim, H. E. Park, et al. 2014. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis. Cardiovasc. Res. 101: 203–210
   PubMed Web of Science ®Google Scholar
• Lim, D. S., M. S. Kang, J. A. Jeong, and Y. S. Bae. 2009. Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. Eur. J. Immunol. 39: 1334–1343
   PubMed Web of Science ®Google Scholar
• Thomson, A. W., and P. D. Robbins. 2008. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann. Rheum. Dis. 67: iii90–iii96
   PubMed Web of Science ®Google Scholar
• Benham, H., H. J. Nel, S. C. Law, et al. 2015. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7: 290ra287
   Web of Science ®Google Scholar
• Healy, L. J., H. L. Collins, and S. J. Thompson. 2008. Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol. J. 2: 71–80
   PubMedGoogle Scholar
• Pedersen, A. W., K. Holmstrom, S. S. Jensen, et al 2009. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin. Exp. Immunol. 157: 48–59
   PubMed Web of Science ®Google Scholar
• Gross, S., and P. Walden. 2008. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol. Lett. 116: 7–14
   PubMed Web of Science ®Google Scholar
• Serafini, P., S. Mgebroff, K. Noonan, and I. Borrello. 2008. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68: 5439–5449
   PubMed Web of Science ®Google Scholar
• Terness, P., M. Kallikourdis, A. G. Betz, et al. 2007. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 58: 238–254
   PubMed Web of Science ®Google Scholar
• Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303–7311
   PubMed Web of Science ®Google Scholar
• Robbins, S. H., T. Walzer, D. Dembele, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9: R17
   PubMed Web of Science ®Google Scholar
• Chen, Y., J. A. Gelfond, L. M. McManus, and P. K. Shireman. 2009. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10: 407
   PubMed Web of Science ®Google Scholar
• Huang da, W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4: 44–57
   PubMed Web of Science ®Google Scholar
• Bros, M., F. Jahrling, A. Renzing, et al. 2007. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 109: 3820–3829
   PubMed Web of Science ®Google Scholar
• Wong, K. L., J. J. Tai, W. C. Wong, et al. 2011. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16–e31
   PubMed Web of Science ®Google Scholar
• Crozat, K., R. Guiton, M. Guilliams, et al. 2010. Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol. Rev. 234: 177–198
   PubMed Web of Science ®Google Scholar
• Hoheisel, J. D. 2006. Microarray technology: beyond transcript profiling and genotype analysis. Nat. Rev. Genet. 7: 200–210
   PubMed Web of Science ®Google Scholar